Claire Grosu, PhD, is affiliated with the Unit of Pharmacogenetics and Clinical Psychopharmacology at the Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, University of Lausanne in Prilly, Switzerland. Grosu has published research focused on the effects of psychotropic medication doses, specifically valproate and risperidone, on weight and metabolic parameters in adult psychiatric patients with conditions including bipolar disorder and psychotic disorders. Her work, appearing between 2022 and 2024 in Psychiatrist.com, addresses the intersection of psychiatric treatment and metabolic health.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
